Literature DB >> 37314

Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation.

L A Wakile, T P Sloan, J R Idle, R L Smith.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 37314     DOI： 10.1111/j.2042-7158.1979.tb13520.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  4 in total

Review 1.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

Review 2.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

3.  Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

Authors:  M Oram; K Wilson; D Burnett; S G Al-Dabbagh; J R Idle; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver.

Authors:  G C Kahn; A R Boobis; S Murray; M J Brodie; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.